Japan Favors 'Bio-betters' Over Biosimilars
This article was originally published in PharmAsia News
Executive Summary
Takao Hayakawa of Japan's Pharmaceuticals and Medical Devices Agency recently laid out the philosophy Japan has taken toward biosimilars in its March 2009 guidelines